Search results
From WikiAnesthesia
Did you mean: nondepolarizing neuromuscular blocker
- Rocuronium (category Nondepolarizing neuromuscular blockers)Butterworth IV, John F.; Mackey, David C.; Wasnick, John D. (2022), "Neuromuscular Blocking Agents", Morgan & Mikhail’s Clinical Anesthesiology (7 ed.), New2 KB (86 words) - 14:27, 22 December 2022
- Vecuronium (category Nondepolarizing neuromuscular blockers)clinical practice Lien, Cynthia A.; Eikermann, Matthias (2013), "Neuromuscular Blockers and Reversal Drugs", Pharmacology and Physiology for Anesthesia5 KB (420 words) - 09:10, 5 January 2023
- Cisatracurium (category Nondepolarizing neuromuscular blockers)Cisatracurium is a benzylisoquinolinium intermediate acting nondepolarizing neuromuscular blocking agent used for tracheal intubation and surgical relaxation5 KB (449 words) - 14:14, 8 January 2023
- Mivacurium (category Nondepolarizing neuromuscular blockers)in the United States of America Goodwin, G., Joseph, V. (2015). Neuromuscular Blockers. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology6 KB (503 words) - 09:28, 5 January 2023
- Myasthenia gravis (section Neuromuscular blockade)sensitive to nondepolarizing neuromuscular blockers Resistant to succinylcholine At increased risk for developing phase II neuromuscular block, particularly6 KB (544 words) - 04:57, 17 July 2022
- midazolam, ketamine, or dexmedetomidine with a longer acting nondepolarizing neuromuscular blocker infusion. Tend to avoid propofol due to risk of interfering7 KB (731 words) - 12:21, 4 May 2024
File:Obstetric Anesthesia CA1 Lecture 05Feb21.pdf (matches file content) concentration of volatile anesthetics • Increased sensitivity of nondepolarizing neuromuscular blockers • Increased risk of pulmonary edema 8-12 mEq/L • Loss of(1,500 × 843 (1.41 MB)) - 00:35, 17 May 2022
File:Obstetric Anesthesia Review for the Basic Boards 08May18.pdf (matches file content) concentration of volatile anesthetics Increased sensitivity of nondepolarizing neuromuscular blockers Increased risk of pulmonary edema 8-12 mEq/L Loss of deep(1,500 × 843 (1.23 MB)) - 00:33, 17 May 2022- Brugada syndrome (section Neuromuscular blockade)(primarily class 1A and 1C antiarrhythmics) Sugammadex should be used for neuromuscular blockade reversal Manage arrhythmic storm with defibrillation, isoprotenerol19 KB (2,301 words) - 23:40, 11 November 2022
File:Shaydenfish et al reversal AnesthAnalg 2019.pdf (matches file content) primary hypothesis that neuromuscular blocking drug reversal with neostigmine and glycopyrrolate versus no neuromuscular blocking drug reversal is associated(1,218 × 1,631 (373 KB)) - 00:42, 17 May 2022
File:Ruscic 2017 Curr Opin Anes - Respiratory Complications.pdf (matches file content) pressure <55 mmHg) [29 ]. The use of intermediate-acting nondepolarizing neuromuscular blocking agents (NMBAs) is associated with an increased risk of postoperative(1,222 × 1,629 (757 KB)) - 00:42, 17 May 2022
File:Anesthesia for Myocardial Revascularization.pdf (matches file content) cerebral or coronary gaseous emboli. • �Muscle relaxation with nondepolarizing neuromuscular blockers is almost always used. • �Maintain heart rate as low as(900 × 1,350 (775 KB)) - 00:30, 17 May 2022
File:Multimodal analgesic therapy with gabapentin is associated with perioperative respiratory despression (Cavalcante 2017).pdf (matches file content) procedures. Another limitation is that the use and reversal of nondepolarizing neuromuscular blocking drugs was guided by qualitative train-of-four peripheral(1,218 × 1,631 (104 KB)) - 00:35, 17 May 2022
File:Residual neuromuscular blockade and paralysis and negative perioperative outcomes -review- (Farhan 2014).pdf (matches file content) paralysis such as neuromuscular transmission monitoring and judicious use of low-dose neuromuscular blocking drugs. Neuromuscular blocking agent effects should(1,240 × 1,647 (616 KB)) - 00:32, 17 May 2022
File:Intraoperative neuromuscular monitoring site and residual paralysis (Thilen 2012).pdf (matches file content) intense neuromuscular block. Anesth Analg 1994; 78:697-700 13. Rimaniol JM, Dhonneur G, Sperry L, Duvaldestin P: A comparison of the neuromuscular blocking(1,218 × 1,631 (490 KB)) - 00:31, 17 May 2022
File:CA1 Tutorial Book FINAL.pdf (matches file content) cisatracurium) Neuromuscular Blocking Agents (NMBAs) • • Postoperative residual paralysis occurs frequently. Monitoring of neuromuscular blockade and pharmacological(1,125 × 1,500 (7.21 MB)) - 11:03, 3 August 2021
File:OB Oral Board Prep.pdf (matches file content) anesthetic implications, including: a. Potentiation of neuromuscular blockade (for depolarizing and nondepolarizing relaxants), weakness, b. Decreased uterine tone(1,275 × 1,650 (58 KB)) - 00:31, 17 May 2022
File:NMCP Anesthesiology Introductory Guide (rotator manual) Booklet Print.pdf (matches file content) post‐synaptic nicotinic ACh receptors Nondepolarizing NMBA, binds post‐synaptic nicotinic ACh receptors Nondepolarizing NMBA, binds post‐synaptic nicotinic(1,650 × 1,275 (2.25 MB)) - 07:31, 29 August 2023
File:NMCP Anesthesiology Introductory Guide (rotator manual).pdf (matches file content) post-synaptic nicotinic ACh receptors Nondepolarizing NMBA, binds post-synaptic nicotinic ACh receptors Nondepolarizing NMBA, binds post-synaptic nicotinic(825 × 1,275 (1.49 MB)) - 07:39, 29 August 2023